Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 550444

OnabotulinumtoxinA for treatment of chronic migraine : Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

Aurora, S.K.; Dodick, D.W.; Turkel, C.C.; DeGryse, R.E.; Silberstein, S.D.; Lipton, R.B.; Diener, H.C.; Brin, M.F.; PREEMPT 1 Chronic Migraine Study Group; Becker, W.J. et al.
OnabotulinumtoxinA for treatment of chronic migraine : Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial // Cephalalgia (Oslo), 30 (2010), 7; 793-803 doi:10.1177/0333102410364676 (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 550444 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
OnabotulinumtoxinA for treatment of chronic migraine : Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

Autori
Aurora, S.K. ; Dodick, D.W. ; Turkel, C.C. ; DeGryse, R.E. ; Silberstein, S.D. ; Lipton, R.B. ; Diener, H.C. ; Brin, M.F. ; PREEMPT 1 Chronic Migraine Study Group ; Becker, W.J. ; Blumenfeld, A. ; Cutrer, F.M. ; Gendolla, A. ; Lay, C. ; Martin, V. ; Relja, Maja ; Schim, J.D. ; Smith, T.R. ; Ward, T.W. ; Winner, P.

Izvornik
Cephalalgia (Oslo) (0333-1024) 30 (2010), 7; 793-803

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
chronic migraine; cnabotulinumtoxinA; prophylaxis

Sažetak
There was no between-group difference for the primary endpoint, headache episodes. However, significant reductions from baseline were observed for onabotulinumtoxinA for headache and migraine days, cumulative hours of headache on headache days and frequency of moderate/severe headache days, which in turn reduced the burden of illness in adults with disabling chronic migraine.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Projekti:
108-1080003-0019 - Klinička farmakologija poremećaja pokreta (Relja, Maja, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb

Profili:

Avatar Url Maja Relja (autor)

Poveznice na cjeloviti tekst rada:

doi www.ncbi.nlm.nih.gov cep.sagepub.com

Citiraj ovu publikaciju:

Aurora, S.K.; Dodick, D.W.; Turkel, C.C.; DeGryse, R.E.; Silberstein, S.D.; Lipton, R.B.; Diener, H.C.; Brin, M.F.; PREEMPT 1 Chronic Migraine Study Group; Becker, W.J. et al.
OnabotulinumtoxinA for treatment of chronic migraine : Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial // Cephalalgia (Oslo), 30 (2010), 7; 793-803 doi:10.1177/0333102410364676 (međunarodna recenzija, članak, znanstveni)
Aurora, S., Dodick, D., Turkel, C., DeGryse, R., Silberstein, S., Lipton, R., Diener, H., Brin, M., PREEMPT 1 Chronic Migraine Study Group & Becker, W. (2010) OnabotulinumtoxinA for treatment of chronic migraine : Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia (Oslo), 30 (7), 793-803 doi:10.1177/0333102410364676.
@article{article, author = {Aurora, S.K. and Dodick, D.W. and Turkel, C.C. and DeGryse, R.E. and Silberstein, S.D. and Lipton, R.B. and Diener, H.C. and Brin, M.F. and Becker, W.J. and Blumenfeld, A. and Cutrer, F.M. and Gendolla, A. and Lay, C. and Martin, V. and Relja, Maja and Schim, J.D. and Smith, T.R. and Ward, T.W. and Winner, P.}, year = {2010}, pages = {793-803}, DOI = {10.1177/0333102410364676}, keywords = {chronic migraine, cnabotulinumtoxinA, prophylaxis}, journal = {Cephalalgia (Oslo)}, doi = {10.1177/0333102410364676}, volume = {30}, number = {7}, issn = {0333-1024}, title = {OnabotulinumtoxinA for treatment of chronic migraine : Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial}, keyword = {chronic migraine, cnabotulinumtoxinA, prophylaxis} }
@article{article, author = {Aurora, S.K. and Dodick, D.W. and Turkel, C.C. and DeGryse, R.E. and Silberstein, S.D. and Lipton, R.B. and Diener, H.C. and Brin, M.F. and Becker, W.J. and Blumenfeld, A. and Cutrer, F.M. and Gendolla, A. and Lay, C. and Martin, V. and Relja, Maja and Schim, J.D. and Smith, T.R. and Ward, T.W. and Winner, P.}, year = {2010}, pages = {793-803}, DOI = {10.1177/0333102410364676}, keywords = {chronic migraine, cnabotulinumtoxinA, prophylaxis}, journal = {Cephalalgia (Oslo)}, doi = {10.1177/0333102410364676}, volume = {30}, number = {7}, issn = {0333-1024}, title = {OnabotulinumtoxinA for treatment of chronic migraine : Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial}, keyword = {chronic migraine, cnabotulinumtoxinA, prophylaxis} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.